Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Parkin et al 2002 United Kingdom | 64 patients attending for first treatment lithotripsy for kidney stones. 34 - Given Diclofenac (100mg PR) alone GROUP A 30 - Diclofenac (100mg PR) and Alfentanil via PCA GROUP B Exclusion criteria - NSAID allergy, concurrent analgesia, previous lithotripsy and inability to consent or use PCA. | Prospective Randomised Controlled Trial | Visual Analogue Score (VAS) 1-10 about maximum pain experienced during procedure and satisfaction with treatment 1-10 asked immediately after the procedure. | No difference in mean pain score between Group A and Group B 3.54 to 2.93 P=0.34 respectively. Satisfaction score significantly higher in PCA group 7.72 to 9.14 p = 0.04. No signifcant side effects reported in any patients. | Open to expectation bias in PCA group. Unclear whether power of study sufficient to detect a difference in pain score. Influence of variation in stone location along urinary tract not analysed. |
Hector et al 2005 The Netherlands | 200 patients undergoing Extracorporeal Shock Wave Lithotripsy(ESWL) for Kidney stones. ASA score I - II aged 18-80y/o. 100 - 0.05mcg/kg/min infusion of remifentanil Group 1 100 - 0.1mcg/kg/min infusion of remifentanil Group 2 | Double Blind Randomised Controlled Trial | PCA demand frequency and actual boluses delivered. Visual Analogue Score (VAS) 1-10 of pain pre-op, immediately postop and 30 mins post-op. Post treatment nausea and vomiting, dizziness, itching, agitation and respiratory depression. | No significant difference in VAS Score with P<0.05. Reduced nausea and vomiting, dizziness and itch in lower dose group. | No control to establish role of remifentanil as drug of choice over other analgesics. No quantification of satisfaction of analgesic effect but just pain scores without context. |
Schelling et al 1996 Germany | 44 patients aged 18 or over attending for first session of Extracorporeal Shock Wave Lithotripsy for calculi in renal pelvis. 22 - Alfentanil infusion titrated by Anaesthesiologist GROUP 1 22 - Alfentanil administered by PCA GROUP 2 Exclusion criteria - alcohol abuse, chronic pain, opioids in last 7 days. | Prospective Randomised Controlled Trial. | Infusion rate of alfentanil required for tolerance of shock waves. Number of attempts and number of actual deliveries in PCA group. Total amount of alfentanil required in both groups. Pain severity at 10 minute intervals during treatment on a verbal rating scale 0-5. Level of sedation on a scale 0-5 at 10 minute intervals during procedure. Tolerance to procedure asked 24 hours afterwards. | No statistical difference between groups for pain and tolerance. PCA patients required fewer shock waves but no difference in total energy as tolerated higher discharge voltages. PCA group required significantly less drug 0.83 +/- 0.67mg vs 2.2 +/- 0.92mg P = 0.006 No adverse effects observed in any patient. | Unvalidated method of pain scoring and tolerance scoring. |